OVUTRIG HP 5000iu INJECTION

Indications

• Infertility treatment in women
• Triggering ovulation
• Hypogonadism in men
• Support of early pregnancy

Dosage

Children: Refer to the BNF for Children for specific dosing.

Adults: Refer to relevant clinical guidelines for specific dosing.

Mechanism of action

Chorionic gonadotropin exerts its effects by binding to the luteinizing hormone (LH) receptor, which is expressed in the ovaries and testes. This binding activates the receptor, leading to a cascade of intracellular signaling that promotes steroidogenesis-enhancing the synthesis of progesterone in females and testosterone in males. It mimics the action of LH, thus playing a crucial role in ovulation and maintaining the corpus luteum.

Pharmacodynamics

The pharmacodynamic effects of chorionic gonadotropin include stimulation of ovarian follicle maturation and ovulation in women, and stimulation of testosterone production and spermatogenesis in men. The effects are dose-dependent and can vary based on the route of administration and the specific clinical scenario. In fertility treatments, hCG is used to trigger ovulation, while in men, it can be used to treat hypogonadism.

Pharmacokinetics

Chorionic gonadotropin is administered via subcutaneous or intramuscular injection. After administration, it is absorbed into the bloodstream, with peak plasma concentrations occurring about 24 to 48 hours post-injection. The half-life of hCG is approximately 24 to 36 hours, and it is primarily eliminated through renal excretion. The pharmacokinetics may be influenced by the patient's weight, age, and other individual factors.

Adverse effects

• Nausea
• Vomiting
• Headache
• Abdominal pain
• Ovarian hyperstimulation syndrome (OHSS)
• Injection site reactions

Precautions

• Use with caution in patients with a history of thrombosis or thromboembolic disorders.
• Monitor for signs of OHSS, especially in women undergoing assisted reproductive techniques.
• Evaluate liver and kidney function prior to administration.

Pregnancy

Chorionic is used in pregnancy to support luteal phase and early pregnancy; however, its use should be carefully monitored.

Breast-feeding

Limited data available; use with caution and consult with a healthcare provider.

Storage

Store in a refrigerator (2-8 degrees Celsius). Protect from light. Do not freeze.

Formulations

• Chorionic gonadotropin injection
• Chorionic gonadotropin nasal spray

Indications

• Anovulation
• Infertility
• Hypogonadism
• Assisted reproductive technology (ART)
• Ovarian stimulation

Dosage

Children: Refer to the BNF for Children for dosing information as it varies according to the specific clinical scenario and individual patient

Adults: Dosing regimens vary based on the specific gonadotrophin and clinical indication. Refer to specific guidelines or the relevant BNF for detailed dosing information.

Mechanism of action

Gonadotrophins act by binding to specific receptors on the surface of gonadal cells. FSH primarily promotes the growth and maturation of ovarian follicles in females and spermatogenesis in males. LH triggers ovulation and promotes the secretion of sex steroids, such as estrogen and testosterone, from the gonads. This action is mediated through the activation of adenylate cyclase, leading to increased cyclic AMP levels and subsequent activation of protein kinase A.

Pharmacodynamics

The pharmacodynamics of gonadotrophins involves the regulation of reproductive hormones and the reproductive cycle. FSH stimulates the development of ovarian follicles and the production of estrogen, while LH is responsible for triggering ovulation and supporting luteal function through progesterone secretion. Their synergistic action is crucial for normal reproductive function and fertility.

Pharmacokinetics

Gonadotrophins are administered via injection, as they are not effective orally due to degradation in the gastrointestinal tract. They have a variable half-life depending on the specific type of gonadotrophin used, with FSH typically having a half-life of 3-4 hours and LH having a shorter half-life. The pharmacokinetics may also be influenced by the formulation (e.g., recombinant versus urinary-derived). The gonadotrophins are metabolized in the liver and excreted via the kidneys.

Contra-indications

• Hypersensitivity to gonadotrophins or any of their excipients
• Tumors of the pituitary gland or hypothalamus
• Ovarian cysts or enlarged ovaries not caused by polycystic ovary syndrome
• Primary ovarian insufficiency

Adverse effects

• Ovarian hyperstimulation syndrome (OHSS)
• Multiple pregnancies
• Headache
• Nausea
• Abdominal pain
• Injection site reactions
• Mood swings
• Breast tenderness

Interactions

• Corticosteroids may reduce the effectiveness of gonadotrophins
• Other hormone treatments may interact with gonadotrophins

Precautions

• Monitor for signs of OHSS
• Use with caution in patients with a history of thromboembolic disorders
• Careful consideration in patients with liver or kidney disease

Pregnancy

Gonadotrophins are contraindicated in pregnancy due to the potential for inducing ovarian hyperstimulation syndrome and promoting multiple gestations.

Breast-feeding

There is limited data on the excretion of gonadotrophins in breast milk; caution is advised when administering to breastfeeding mothers.

Storage

Store in a refrigerator (2-8°C). Protect from light. Do not freeze.

Formulations

• Human chorionic gonadotropin (hCG)
• Follicle-stimulating hormone (FSH)
• Luteinizing hormone (LH)
• Recombinant gonadotrophins

Dosage

Children: Refer to specific drug guidelines or BNF for Children for appropriate dosing information in paediatric populations.

Adults: Refer to specific drug guidelines or BNF for appropriate dosing information, as this can vary widely based on the condition being treated.

Mechanism of action

The mechanism of action would depend on the specific drug in question. Generally, medications work by interacting with specific receptors, enzymes, or pathways in the body, leading to therapeutic effects. For example, some drugs may inhibit enzymes that contribute to disease processes, while others may modulate receptor activity to enhance or inhibit physiological responses.

Pharmacodynamics

Pharmacodynamics involves the study of the effects of drugs and their mechanisms of action in the body. The relationship between drug concentration and its effect can vary widely among different classes of medications. Highly effective drugs may have a steep dose-response curve, meaning small changes in dose can lead to significant changes in effect.

Pharmacokinetics

Pharmacokinetics describes the absorption, distribution, metabolism, and excretion (ADME) of drugs. Highly effective medications may have specific pharmacokinetic profiles that optimize their therapeutic effects while minimizing side effects. This includes considerations like half-life, bioavailability, and clearance rates which can influence dosing regimens.

Pregnancy

Consult with a healthcare provider before use; safety profile during pregnancy is not well established.

Breast-feeding

Consult with a healthcare provider; safety during breastfeeding is not well established.

Storage

Store in a cool, dry place away from direct sunlight and out of reach of children.

Dosage

Children: Refer to specific drug formulations and product labels as purified substances can vary widely in their use and dosing.

Adults: Refer to specific drug formulations and product labels as purified substances can vary widely in their use and dosing.

Mechanism of action

The mechanism of action for purified compounds varies widely depending on the specific substance. Generally, purified drugs exert their effects by interacting with specific biological targets, such as receptors, enzymes, or ion channels, leading to a desired therapeutic effect. This interaction can involve binding to receptors to activate or inhibit signaling pathways, modulating enzymatic activity, or altering physiological processes.

Pharmacodynamics

Pharmacodynamics describes the effects of a drug on the body and the relationship between drug concentration and effect. For purified drugs, this can involve dose-response relationships and the time course of their action. The purified form often enhances potency and reduces variability in response among patients, which can lead to more predictable therapeutic outcomes. The overall effect is determined by the drug's affinity for its target, the efficacy of the drug-receptor interaction, and the downstream signaling pathways activated as a result of this interaction.

Pharmacokinetics

Pharmacokinetics involves the absorption, distribution, metabolism, and excretion (ADME) of a drug. For purified substances, absorption can be more efficient due to the absence of impurities that may affect solubility or stability. Distribution may also be enhanced, leading to higher bioavailability. Metabolism can be influenced by the structure of the purified compound, as it may be metabolized more readily by liver enzymes. Excretion typically occurs through the kidneys or liver, depending on the molecular characteristics of the purified drug.

Pregnancy

Consult with a healthcare professional, as the safety of purified forms of medications during pregnancy may vary depending on the specific substance.

Breast-feeding

Consult with a healthcare professional, as the safety of purified forms of medications during breastfeeding may vary depending on the specific substance.

Storage

Store in a cool, dry place, away from light and moisture, and keep out of reach of children.